Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 167
Filter
1.
Leukemia ; 31(11): 2303-2314, 2017 11.
Article in English | MEDLINE | ID: mdl-28210006

ABSTRACT

Lysine-specific demethylase 1 (LSD1) regulates gene expression by affecting histone modifications and is a promising target for acute myeloid leukemia (AML) with specific genetic abnormalities. Novel LSD1 inhibitors, NCD25 and NCD38, inhibited growth of MLL-AF9 leukemia as well as erythroleukemia, megakaryoblastic leukemia and myelodysplastic syndromes (MDSs) overt leukemia cells in the concentration range that normal hematopoiesis was spared. NCD25 and NCD38 invoked the myeloid development programs, hindered the MDS and AML oncogenic programs, and commonly upregulated 62 genes in several leukemia cells. NCD38 elevated H3K27ac level on enhancers of these LSD1 signature genes and newly activated ~500 super-enhancers. Upregulated genes with super-enhancer activation in erythroleukemia cells were enriched in leukocyte differentiation. Eleven genes including GFI1 and ERG, but not CEBPA, were identified as the LSD1 signature with super-enhancer activation. Super-enhancers of these genes were activated prior to induction of the transcripts and myeloid differentiation. Depletion of GFI1 attenuated myeloid differentiation by NCD38. Finally, a single administration of NCD38 causes the in vivo eradication of primary MDS-related leukemia cells with a complex karyotype. Together, NCD38 derepresses super-enhancers of hematopoietic regulators that are silenced abnormally by LSD1, attenuates leukemogenic programs and consequently exerts anti-leukemic effect against MDS-related leukemia with adverse outcome.


Subject(s)
Benzamides/pharmacology , Enhancer Elements, Genetic , Enzyme Inhibitors/pharmacology , Histone Demethylases/antagonists & inhibitors , Leukemia/pathology , Myelodysplastic Syndromes/complications , Animals , Cell Division/drug effects , Cell Line, Tumor , Humans , Karyotyping , Leukemia/etiology , Leukemia/genetics , Mice , Mice, Inbred NOD
2.
Oral Dis ; 21(3): 335-41, 2015 Apr.
Article in English | MEDLINE | ID: mdl-25135460

ABSTRACT

OBJECTIVES: The purpose of this study was to investigate the association of the shape of the mandibular cortex on panoramic radiographs with the risk of an osteoporosis diagnosis without prevalent fractures and with the risk of osteoporotic fractures in Japanese men and women. SUBJECTS AND METHODS: One thousand and twenty-one subjects aged 40-89 years, who visited our university hospital and underwent panoramic radiography between 2007 and 2013, participated in this study. Eighty-eight patients received a diagnosis of osteoporosis without prevalent fractures, and 55 were diagnosed with osteoporotic fractures. Blinded to the groupings, we classified the shape of the mandibular cortex on panoramic radiographs as normal, moderately eroded or severely eroded. RESULTS: After adjustment for confounding factors, the odds ratios for an osteoporosis diagnosis associated with moderately eroded and severely eroded mandibular cortices were 1.4 (95% CI, 0.8-2.6) and 2.6 (95% CI, 1.4-5.0), respectively. The odds ratios for an osteoporotic fracture associated with moderately eroded and severely eroded cortices were 0.8 (95% CI, 0.4-1.7) and 1.1 (95% CI, 0.5-2.5), respectively. CONCLUSIONS: Subjects in Japan with eroded mandibular cortices tended to be at increased risk of osteoporosis diagnoses but not of fractures.


Subject(s)
Mandible/diagnostic imaging , Osteoporosis/diagnosis , Osteoporotic Fractures/diagnosis , Adult , Aged , Aged, 80 and over , Female , Humans , Japan/epidemiology , Male , Middle Aged , Osteoporosis/epidemiology , Osteoporotic Fractures/epidemiology , ROC Curve , Radiography, Panoramic , Risk Factors
3.
Dentomaxillofac Radiol ; 40(3): 154-9, 2011 Mar.
Article in English | MEDLINE | ID: mdl-21346081

ABSTRACT

OBJECTIVE: The cortical width below the mental foramen of the mandible determined from panoramic radiographs is a useful screening tool for identifying elderly individuals with a low skeletal bone mineral density (BMD). However, whether the mandible cortical width (MCW) is useful for identifying a low skeletal BMD in men and women of 40 years or younger is not known. METHODS: The BMD of the calcaneus was measured by ultrasonography bone densitometry in 158 men and 76 women aged 18-36 years. A logistic regression analysis adjusted for age was used to calculate the odds ratios and 95% confidence interval (CI) of having a low calcaneal BMD, according to the quartiles of the MCW. The areas under the receiver operator characteristic curve (AUC) for identifying participants with a low calcaneal BMD using the MCW were assessed to evaluate the diagnostic efficacy of the MCW. RESULTS: In men, the adjusted odds ratios of a low calcaneal BMD associated with the second, third and lowest quartiles of MCW were 5.66 (95% CI, 0.61-52.23), 5.43 (95% CI, 0.59-50.18) and 33.22 (95% CI, 3.97-276.94), respectively, compared with the highest quartile, while no significant trend in the adjusted odds ratios was observed in women. The AUC for identifying participants with a low calcaneal BMD based on the MCW was 0.796 (95% CI, 0.702-0.890) in men and 0.593 (95% CI, 0.398-0.788) in women. CONCLUSION: MCW determined from panoramic radiographs can be used to identify undetected low calcaneus BMD in young adult men, but not in young adult women.


Subject(s)
Calcaneus/diagnostic imaging , Mandibular Diseases/diagnostic imaging , Osteoporosis/diagnostic imaging , Radiography, Panoramic , Adolescent , Adult , Area Under Curve , Bone Density , Confidence Intervals , Female , Humans , Japan , Logistic Models , Male , Odds Ratio , Predictive Value of Tests , Sex Factors , Young Adult
5.
Aktuelle Urol ; 41 Suppl 1: S30-3, 2010 Jan.
Article in English | MEDLINE | ID: mdl-20094949

ABSTRACT

BACKGROUND: Scant evidence has been reported on the evaluation of quality-of-life (QOL) in patients who had undergone surgical treatment due to pelvic floor prolapse including cystocele. The aim of this study is to evaluate the impact of surgical intervention on patients' QOL before and after surgery. METHODS: Between 1997 and 2007, 135 patients (median age: 66.6 years) with pelvic floor prolapse including cystocele underwent bladder neck suspension with anterior/posterior colporrhaphy. The follow-up period was 39.6 months. Seventy-two patients (53 %) had urinary incontinence. The cystocele was graded as mild (grade 2), moderate (grade 3), and severe (grade 4) in 35, 60, and 40, respectively, according to the Baden-Walker classification. A urodynamic study was performed in 69 patients (51 %) who had obstructive symptoms with 100 ml or more of postvoid residual urine. Postoperative QOL was longitudinally assessed in 114 patients by scoring three disease-specific items (sensation of vaginal bulging, obstructive symptoms, urinary incontinence), and one overall health-related QOL (HR-QOL), and compared with corresponding baseline scores. RESULTS: A longitudinal study demonstrated that a significant improvement in these symptoms was sustained at a median follow-up of 62.2 months. HR-QOL was significantly associated with vitality assessed by SF 36 (p = 0.036). Multivariate analysis revealed that update urinary incontinence, pre-operative HR-QOL was independent prognostic factors for predicting postoperative patient's satisfaction. CONCLUSIONS: Although surgical repair of pelvic floor prolapse can achieve acceptable results with intermediate-term durability as well as improving the QOL, preoperative patients' HR-QOL may be considered in the decision making process for treatment.


Subject(s)
Cystocele/psychology , Cystocele/surgery , Postoperative Complications/psychology , Quality of Life/psychology , Rectocele/psychology , Rectocele/surgery , Urinary Incontinence/psychology , Urinary Incontinence/surgery , Uterine Prolapse/psychology , Uterine Prolapse/surgery , Adult , Aged , Aged, 80 and over , Female , Humans , Longitudinal Studies , Middle Aged , Patient Satisfaction , Pelvic Floor/surgery
6.
Eur J Gynaecol Oncol ; 30(2): 216-9, 2009.
Article in English | MEDLINE | ID: mdl-19480261

ABSTRACT

We report a case of uterine angiomyolipoma confirmed with molecular-genetic analysis by fluorescence in situ hybridization (FISH). A 25-year-old nulliparous woman visited Yamaguchi University Hospital with a complaint of lower abdominal pain. Magnetic resonance imaging demonstrated an ill-bordered uterine tumor and exploratory laparotomy revealed a myometrial elastic-soft tumor at the anterior wall of the uterine corpus. Histopathologically, the tumor consisted of fascicles of smooth muscle cells with intermingled adipocytes and small to medium-sized arterial blood vessels surrounded by epithelioid cells of clear cytoplasm. FISH examination revealed chromosome X trisomy, which was comparable to a previously reported molecular-genetic finding of PEComa family tumors including angiomyolipoma. Although the tumor was immunohistochemically negative for HMB-45 antigen, the histological and FISH findings were compatible with angiomyolipoma.


Subject(s)
Antigens, Neoplasm/analysis , Biomarkers, Tumor/analysis , Neoplasm Proteins/analysis , Perivascular Epithelioid Cell Neoplasms/diagnosis , Uterine Neoplasms/diagnosis , Adult , Angiomyolipoma/diagnosis , Angiomyolipoma/immunology , Angiomyolipoma/pathology , Chromosomes, Human, X/genetics , Cytogenetic Analysis , Female , Humans , In Situ Hybridization, Fluorescence , Melanoma-Specific Antigens , Perivascular Epithelioid Cell Neoplasms/immunology , Perivascular Epithelioid Cell Neoplasms/pathology , Trisomy , Uterine Neoplasms/immunology , Uterine Neoplasms/pathology
7.
Tumour Biol ; 30(1): 26-36, 2009.
Article in English | MEDLINE | ID: mdl-19194112

ABSTRACT

Eight monoclonal antibodies directed against Squamous Cell Carcinoma Antigens (A1 and A2) were collected and evaluated by three working groups. Recombinant antigens, fusion proteins and native antigens from normal tissue were used to evaluate antibody specificity. Five antibodies reacted with both A1 and A2. Two of these antibodies (K123 and K131) showed related binding characteristics, whereas SCC140, K182 and SCC111 demonstrated unique epitope specificity and were not related to the reference antibodies included (F1H3, F2H7 and SCC107). SCC111 reacted particularly well with antigen on Western blot, indicating that the epitope was partly hidden when the antigen was in solution. Two antibodies (SCC103 and SCC109) reacted only with A2 and the fusion protein A1/A2, indicating that they recognized an A2 epitope in exon 8. The A2-specific antibodies are unique in their binding to A2 and are different from the reference antibodies included (SCC104 and K122). SCC103 is probably the best A2-specific antibody available. One antibody, K136, was A1-specific and is related to reference antibody K135. The new antibodies can be used to establish immunometric assays for specific measurement of A1, A2 or both A1 and A2 together.


Subject(s)
Antibodies, Monoclonal/analysis , Antigens, Neoplasm/immunology , Carcinoma, Squamous Cell/immunology , Serpins/immunology , Animals , Antibodies, Monoclonal/immunology , Antibody Specificity , Epitope Mapping , Epitopes/immunology , Exons/immunology , Immunohistochemistry/methods , Mice , Recombinant Proteins/immunology , Sheep
8.
Hum Reprod ; 23(2): 285-9, 2008 Feb.
Article in English | MEDLINE | ID: mdl-18037605

ABSTRACT

BACKGROUND: Changes in blood flow impedance of the uterine artery (UA) and uterine radial artery (RA) which is in the lower-extremity of the UA were examined during early pregnancy. METHODS: Blood flow impedance was assessed by transvaginal color-pulsed-Doppler-ultrasonography in 72 women from weeks 4-16 of pregnancy and expressed as a resistance index (RI). RESULTS: RA-RI remained at the late-luteal phase level until the 5th week of pregnancy, decreased until the 7th week, and remained low until the 10th week. UA-RI remained at the late-luteal phase level until the 10th week, and then gradually decreased until the 16th week. In nine women with spontaneous abortion, five out of six women with impaired growth of the gestational sac showed high RA-RI at the 6th week of pregnancy, whereas all three women with loss of fetal heart beat at the 8th week showed normal changes in RA-RI. CONCLUSIONS: Our results show different changes in blood flow impedance between the UA and RA during early pregnancy. A significant decrease of RA-RI after the 5th week may reflect vascular remodeling in the maternal-fetal interface at placentation, whereas a significant decrease of UA-RI after the 10th week may reflect changes of the whole uterine blood flow associated with uterine growth.


Subject(s)
Pregnancy , Uterus/blood supply , Vascular Resistance , Abortion, Spontaneous/physiopathology , Adult , Arteries/diagnostic imaging , Female , Fetal Death , Humans , Luteal Phase , Pregnancy Complications/physiopathology , Pregnancy Trimester, First , Pregnancy Trimester, Second , Regional Blood Flow , Ultrasonography, Doppler, Color , Ultrasonography, Doppler, Pulsed
10.
Placenta ; 28 Suppl A: S133-6, 2007 Apr.
Article in English | MEDLINE | ID: mdl-17291583

ABSTRACT

Cells living under aerobic conditions always face an oxygen paradox. Oxygen is necessary for cells to maintain their lives. However, toxic reactive oxygen species such as the superoxide radical, the hydroxyl radical and hydrogen peroxide are generated from oxygen and damage cells. Oxidative stress occurs as a consequence of excessive production of reactive oxygen species or impaired antioxidant defense systems. Antioxidant enzymes include two types of superoxide dismutase (SOD), which specifically scavenges superoxide radicals: copper-zinc SOD, which is located in the cytosol and Mn-SOD, which is located in the mitochondria. SOD is the first enzymatic step in the defense system against oxidative stress. In addition to ovarian steroid hormones, a number of local factors such as cytokines, growth factors and eicosanoids have been reported to be involved in the regulation of endometrial function. Recently, much attention has been focused on the finding that reactive oxygen species act as second messengers in the regulation of cellular function. Since reactive oxygen species are generated, and SOD is expressed, in the endometrium, it is possible that reactive oxygen species and SOD work as local regulators of endometrial function. The present review summarizes recent findings that reactive oxygen species and SOD play important roles in the process of reproductive physiology such as decidualization and menstruation in the human endometrium.


Subject(s)
Endometrium/physiology , Reactive Oxygen Species/metabolism , Superoxide Dismutase/physiology , Decidua/cytology , Decidua/metabolism , Decidua/physiology , Embryo Implantation/genetics , Embryo Implantation/physiology , Endometrium/enzymology , Endometrium/metabolism , Female , Humans , Menstrual Cycle/genetics , Menstrual Cycle/metabolism , Oxidative Stress , Signal Transduction , Superoxide Dismutase/genetics
11.
Reproduction ; 123(3): 379-87, 2002 Mar.
Article in English | MEDLINE | ID: mdl-11882015

ABSTRACT

Immunohistochemistry for vascular endothelial growth factor (VEGF) and its receptors, fms-like tyrosine kinase (flt-1) and kinase insert domain-containing region (KDR), was performed on human endometrium obtained from patients with normal menstrual cycles, patients given oestrogen and progesterone, and women in early pregnancy. Intense immunostaining of VEGF was observed in both glandular epithelial and stromal cells during the mid-secretory phase; the immunostaining intensity was increased by administration of oestrogen plus progesterone and strong immunostaining was observed in decidual cells of early pregnancy. In addition to the immunostaining in vascular endothelial cells, strong KDR immunostaining was observed in glandular epithelial cells and in decidualized stromal cells induced by administration of oestrogen plus progesterone, whereas flt-1 immunostaining was negligible. Strong immunostaining for flt-1 and KDR was found in both vascular endothelial cells and decidual cells in early pregnancy. Endometrial stromal cells isolated from proliferative phase endometrium were incubated with oestrogen (10(-8) mol l-1) and medroxyprogesterone acetate (MPA; 10(-6) mol l-1) for 18 days to study the regulation of VEGF, flt-1 and KDR in endometrial stromal cells by oestrogen and progesterone. Expression of VEGF and KDR mRNAs was increased significantly by oestrogen and MPA, accompanied by decidualization, whereas flt-1 mRNA expression was not affected. In conclusion, VEGF and its receptors may play important roles in implantation and maintenance of pregnancy.


Subject(s)
Endometrium/metabolism , Endothelial Growth Factors/metabolism , Lymphokines/metabolism , Menstrual Cycle/metabolism , Pregnancy/metabolism , Receptor Protein-Tyrosine Kinases/metabolism , Receptors, Growth Factor/metabolism , Adult , Analysis of Variance , Cells, Cultured , Decidua/chemistry , Decidua/metabolism , Endometrium/chemistry , Endothelial Growth Factors/analysis , Endothelial Growth Factors/genetics , Endothelium, Vascular/chemistry , Endothelium, Vascular/metabolism , Estrogens/pharmacology , Extracellular Matrix Proteins/analysis , Extracellular Matrix Proteins/genetics , Extracellular Matrix Proteins/metabolism , Female , Humans , Immunohistochemistry , Lymphokines/analysis , Lymphokines/genetics , Medroxyprogesterone Acetate/pharmacology , Middle Aged , RNA, Messenger/analysis , Receptor Protein-Tyrosine Kinases/analysis , Receptor Protein-Tyrosine Kinases/genetics , Receptors, Growth Factor/analysis , Receptors, Growth Factor/genetics , Receptors, Vascular Endothelial Growth Factor , Reverse Transcriptase Polymerase Chain Reaction , Stromal Cells/chemistry , Stromal Cells/metabolism , Vascular Endothelial Growth Factor A , Vascular Endothelial Growth Factor Receptor-1 , Vascular Endothelial Growth Factors
12.
Reproduction ; 122(6): 875-81, 2001 Dec.
Article in English | MEDLINE | ID: mdl-11732982

ABSTRACT

The aim of this study was to investigate the expression of vascular endothelial growth factor (VEGF) receptors, the fms-like tyrosine kinase (flt-1) and kinase insert domain-containing region (KDR), in corpora lutea obtained at different stages of the oestrous cycle and during pregnancy in rats. Immunohistochemistry revealed that both flt-1 and KDR were localized in luteal cells in addition to vascular endothelial cells, and that the intensity of staining was stronger in pregnant rats than in cyclic rats. Rats undergoing hypophysectomy-hysterectomy on day 12 of pregnancy were treated with oestradiol until day 15 of pregnancy to determine whether oestradiol is involved in expression of flt-1 and KDR mRNA in the corpus luteum during mid-pregnancy. The flt-1 and KDR mRNA contents in the corpus luteum were decreased significantly by hypophysectomy-hysterectomy, and these decreases recovered significantly after oestradiol treatment. Changes in the mass of the corpus luteum and serum progesterone concentrations paralleled the changes in expression of flt-1 and KDR mRNA. Developmental studies indicated that flt-1 and KDR mRNA contents in the corpus luteum were constant until day 15 of pregnancy but decreased significantly on day 21 of pregnancy. In conclusion, both flt-1 and KDR were expressed in luteal cells in addition to vascular endothelial cells, and expression was upregulated by oestradiol during mid-pregnancy. flt-1 and KDR may play a role in development of the corpus luteum and in production of progesterone during mid-pregnancy in rats.


Subject(s)
Corpus Luteum/chemistry , Estradiol/metabolism , Extracellular Matrix Proteins/analysis , Pregnancy, Animal/metabolism , Receptor Protein-Tyrosine Kinases/analysis , Receptors, Growth Factor/analysis , Animals , Corpus Luteum/drug effects , Corpus Luteum/metabolism , Endothelium, Vascular/chemistry , Endothelium, Vascular/metabolism , Estradiol/pharmacology , Extracellular Matrix Proteins/genetics , Female , Gestational Age , Hypophysectomy , Hysterectomy , Immunohistochemistry/methods , Pregnancy , Progesterone/blood , RNA, Messenger/analysis , Rats , Rats, Sprague-Dawley , Receptor Protein-Tyrosine Kinases/genetics , Receptors, Growth Factor/genetics , Receptors, Vascular Endothelial Growth Factor , Reverse Transcriptase Polymerase Chain Reaction , Vascular Endothelial Growth Factor Receptor-1
13.
Mol Hum Reprod ; 7(11): 1065-72, 2001 Nov.
Article in English | MEDLINE | ID: mdl-11675473

ABSTRACT

The present study was undertaken to investigate the effect of tumour necrosis factor-alpha (TNFalpha) on superoxide dismutase (SOD) expression in human endometrial stromal cells (ESC) and to determine whether there is a difference in responsiveness to TNFalpha between ESC and decidualized ESC. TNFalpha increased manganese-SOD (Mn-SOD) mRNA level and Mn-SOD activity in a dose-dependent manner in ESC. The concentration of TNFalpha required for an effect was lower for decidualized ESC than for non-decidualized ESC. TNFalpha had no effect on copper-zinc-SOD (Cu,Zn-SOD) expression in either type of cell. Incubation of ESC with actinomycin D, an RNA synthesis inhibitor, blocked TNFalpha-induced Mn-SOD mRNA expression, but cycloheximide, a protein synthesis inhibitor, had no effect. H7, an inhibitor of protein kinase C (PKC), also inhibited TNFalpha-stimulated Mn-SOD mRNA expression in both types of cells. These findings suggest that TNFalpha-induced Mn-SOD expression is regulated at the transcription level and mediated by PKC-dependent phosphorylation and that de-novo protein synthesis is not required for the TNFalpha effect. In summary, TNFalpha induces Mn-SOD expression in human ESC. This phenomenon may be important for protection of ESC from cytokine-mediated oxidative stress.


Subject(s)
Endometrium/cytology , Endometrium/physiology , Superoxide Dismutase/genetics , Superoxide Dismutase/metabolism , Tumor Necrosis Factor-alpha/metabolism , 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine/pharmacology , Adult , Cells, Cultured , Cycloheximide/pharmacology , Dactinomycin/pharmacology , Dose-Response Relationship, Drug , Embryo Implantation , Endometrium/drug effects , Enzyme Inhibitors/pharmacology , Female , Humans , Middle Aged , Protein Kinase C/antagonists & inhibitors , Protein Kinase C/drug effects , Protein Kinase C/metabolism , Protein Synthesis Inhibitors/pharmacology , Stromal Cells/drug effects , Stromal Cells/metabolism , Superoxide Dismutase/drug effects , Tetradecanoylphorbol Acetate/pharmacology , Tumor Necrosis Factor-alpha/pharmacology
14.
Hum Reprod ; 16(9): 1797-801, 2001 Sep.
Article in English | MEDLINE | ID: mdl-11527878

ABSTRACT

BACKGROUND: The present study was undertaken to investigate the effect of reactive oxygen species on prostaglandin F2 alpha (PGF2 alpha) production by human endometrial stromal cells (ESC). METHODS AND RESULTS: Isolated ESC were incubated with hydrogen peroxide, which induces lipid peroxidation. Hydrogen peroxide increased both intracellular and medium concentrations of PGF2 alpha (P < 0.01). A time course study showed that hydrogen peroxide significantly increased PGF2 alpha concentrations in the medium after 6 h incubation (P < 0.01), after which no further increase was observed. To study whether the increase in PGF2 alpha production caused by hydrogen peroxide was mediated by cyclooxygenase, ESC were incubated with indomethacin (0.5 microg/ml), an inhibitor of cyclooxygenase, in the presence of hydrogen peroxide. Indomethacin significantly blocked the increases in PGF2 alpha production caused by hydrogen peroxide (P < 0.01). Hydrogen peroxide also increased PGF2 alpha production by decidualized ESC (P < 0.01), induced by the incubation with medroxyprogesterone acetate (10(-6) mol/l) and oestradiol (10(-8) mol/l). CONCLUSIONS: Reactive oxygen species stimulate PGF2 alpha production in ESC, suggesting that they might influence endometrial function by regulating PGF2 alpha production.


Subject(s)
Dinoprost/biosynthesis , Endometrium/metabolism , Reactive Oxygen Species/pharmacology , Stromal Cells/metabolism , Adult , Cells, Cultured , Cyclooxygenase Inhibitors/pharmacology , Decidua/cytology , Decidua/metabolism , Dinoprost/antagonists & inhibitors , Endometrium/cytology , Estradiol/pharmacology , Female , Humans , Hydrogen Peroxide/pharmacology , Indomethacin/pharmacology , Lipid Peroxides/biosynthesis , Medroxyprogesterone Acetate/pharmacology , Osmolar Concentration , Oxidants/pharmacology , Prostaglandin-Endoperoxide Synthases/physiology , Time Factors
15.
Biol Neonate ; 80(1): 81-7, 2001 Jul.
Article in English | MEDLINE | ID: mdl-11474155

ABSTRACT

The effects of intrauterine growth retardation (IUGR) on brain histological or functional development were examined in rats. IUGR was induced by ligating the bilateral uterine arteries at day 17 of pregnancy. On day 22 of pregnancy, cesarean section was performed, and pups with a birth weight of <2 SD of the mean birth weight of control pups were regarded as IUGR rats. Morphological changes of the brain were studied by Nissl's staining at different timepoints during prenatal and postnatal periods. For behavioral study, an open-field test was performed at 5, 7 and 10 weeks after birth. Histological studies showed the migration disorder of the neurons in the cerebral cortex from embryonic day 17 to postnatal day (PD) 49. The open-field test revealed locomotor disturbance at PD49 in male IUGR rats, but not in female IUGR rats or control rats. It is concluded that IUGR due to antenatal ischemia-hypoxia causes morphological changes in the central nervous system, and induces behavioral impairment, particularly in male rats.


Subject(s)
Behavior, Animal , Brain/embryology , Brain/growth & development , Fetal Growth Retardation/complications , Hypoxia-Ischemia, Brain/complications , Animals , Arteries/surgery , Female , Ligation , Male , Motor Activity , Pregnancy , Rats , Rats, Sprague-Dawley , Sex Characteristics , Uterus/blood supply
16.
Fertil Steril ; 75(6): 1224-5, 2001 Jun.
Article in English | MEDLINE | ID: mdl-11384655

ABSTRACT

OBJECTIVE: To report a case of 46,X,der(X)(pter-->q21::p21-->pter) with gonadal dysgenesis, tall stature, and endometriosis. DESIGN: Case report. SETTING: A university hospital. PATIENT(S): A 20-year-old primary amenorrheal woman receiving estrogen-progestogen substitution. INTERVENTION(S): G-banding, comparative genomic hybridization, fluorescence in situ hybridization (FISH), and laparoscopy. MAIN OUTCOME MEASURE(S): A recombinant X chromosome, 46,X,der(X)(pter-->q21::p21-->pter), and pelvic endometriosis. RESULT(S): The patient's chromosomal abnormality was misjudged by the use of G-banding as a distal part deletion of the long arm in one X chromosome. Comparative genomic hybridization and fluorescence in situ hybridization analyses with locus-specific probes revealed 46,X,der(X)(pter-->q21::p21-->pter). The laparoscopic examination showed bilateral streak gonads and blue berry spots at the pelvic peritoneum, which were confirmed by evaluation of biopsy specimens. CONCLUSION(S): Recent advances of genetic strategies make it easy to determine karyotype and phenotype abnormalities. We have to keep our mind on the potential of endometriosis with patients who are receiving estrogen-progestogen substitution.


Subject(s)
Body Height/genetics , Chromosomes, Human, Pair 21/genetics , Endometriosis/genetics , Gonadal Dysgenesis/genetics , Sex Chromosome Aberrations , X Chromosome , Adult , Endometriosis/pathology , Female , Gene Deletion , Gonadal Dysgenesis/pathology , Humans , In Situ Hybridization, Fluorescence , Nucleic Acid Hybridization
17.
J Clin Endocrinol Metab ; 86(3): 1362-9, 2001 Mar.
Article in English | MEDLINE | ID: mdl-11238533

ABSTRACT

Urocortin is a member of the CRF neuropeptide family and has a 43% homology to CRF in amino acid sequence. Urocortin has been found to bind with high affinity to CRF receptors. CRF has been detected in the human ovary and has been demonstrated to suppress ovarian steroidogenesis in vitro. In this study we examined urocortin and CRF receptor expression in normal cycling human ovaries, using immunohistochemistry and RT-PCR. Normal cycling human ovaries were obtained at oophorectomy and hysterectomy from patients who underwent surgery for cervical cancer or myoma uteri. Intense urocortin immunoreactivity was detected in luteinized thecal cells of regressing corpora lutea, in which only luteinized thecal cells have the capacity for steroidogenesis. Immunoreactive urocortin was also detected in luteinized granulosa and thecal cells of functioning corpora lutea, in which both cell components are capable of producing steroids. RT-PCR analyses revealed that messenger ribonucleic acid levels for urocortin, CRF, and CRF receptor type 1 and type 2alpha were significantly higher in the regressing corpus luteum than in the functioning corpus luteum. The spatial and temporal immunolocalization patterns of CRF receptor were similar to those of urocortin. These results suggest that urocortin is locally synthesized in steroidogenic luteal cells and acts on them as an autocrine and/or paracrine regulator of ovarian steroidogenesis, especially during luteal regression.


Subject(s)
Corticotropin-Releasing Hormone/genetics , Gene Expression , Ovary/chemistry , Adult , Cell Nucleus/chemistry , Corpus Luteum/chemistry , Corticotropin-Releasing Hormone/analysis , Cytoplasm/chemistry , Female , Granulosa Cells/chemistry , Humans , Hysterectomy , Immunohistochemistry , Leiomyoma/surgery , Menstrual Cycle , Middle Aged , Ovariectomy , Ovary/metabolism , Ovary/ultrastructure , RNA, Messenger/analysis , Receptors, Corticotropin-Releasing Hormone/analysis , Receptors, Corticotropin-Releasing Hormone/genetics , Reverse Transcriptase Polymerase Chain Reaction , Steroids/biosynthesis , Theca Cells/chemistry , Urocortins , Uterine Cervical Neoplasms/surgery , Uterine Neoplasms/surgery
18.
J Pineal Res ; 30(1): 29-33, 2001 Jan.
Article in English | MEDLINE | ID: mdl-11168904

ABSTRACT

Serum melatonin concentrations were studied in normal pregnant women and in women with several types of pathologic pregnancies, e.g., twins, preeclampsia or intrauterine growth retardation (IUGR). Blood samples were collected from the maternal antecubital vein at 14:00 hr (daytime) and 02:00 hr (nighttime) during pregnancy, and also from the umbilical vein and artery immediately after delivery. Serum melatonin concentrations were measured by radioimmunoassay. Daytime serum melatonin levels in normal (single fetus; singleton) pregnancies were low. While the levels showed an increasing tendency toward the end of pregnancy, no statistically significant changes occurred. On the other hand, the nighttime serum melatonin levels increased after 24 weeks of gestation, with significantly (P < 0.01) high levels after 32 weeks; these values decreased to non-pregnant levels on the 2nd day of puerperium. Nighttime serum melatonin levels were significantly (P < 0.05) higher in twin pregnancies after 28 weeks of gestation than in singleton pregnancies, whereas the patients with severe preeclampsia showed significantly (P < 0.05) lower serum melatonin levels than the mild preeclampsia or the normal pregnant women after 32 weeks of gestation. Melatonin concentrations in umbilical vessels showed a higher tendency in neonates who were born during at night compared with the other neonates; moreover, those in the umbilical artery were generally higher than those in the umbilical vein. The present results indicate that in humans, the maternal serum melatonin levels show a diurnal rhythm, which increases until the end of pregnancy, reflecting some pathologic states of the feto-placental unit. Fetuses may produce melatonin with a circadian rhythm.


Subject(s)
Fetal Growth Retardation/blood , Melatonin/blood , Pre-Eclampsia/blood , Pregnancy/blood , Twins , Adult , Circadian Rhythm/physiology , Female , Humans , Radioimmunoassay , Umbilical Arteries , Umbilical Veins
19.
Biol Reprod ; 64(1): 317-23, 2001 Jan.
Article in English | MEDLINE | ID: mdl-11133689

ABSTRACT

The present study was undertaken to investigate the role of vascular endothelial growth factor (VEGF) in luteal angiogenesis and the regulation of VEGF in the corpus luteum (CL) during mid-pregnancy in rats. Protein concentrations and mRNA levels of VEGF in the CL significantly increased from Day 9 to Day 12 and remained at the same level as Day 12 until Day 15. To study whether estradiol is involved in VEGF expression between Day 12 and Day 15, rats undergoing hypophysectomy-hysterectomy on Day 12 were treated with estradiol until Day 15. Protein concentrations and mRNA levels of VEGF in the CL were significantly decreased by hypophysectomy-hysterectomy, and this inhibitory effect was completely reversed by estradiol treatment. Changes in vascular density in the CL were parallel to those in VEGF expression. To examine whether the effect of estradiol is mediated by VEGF, anti-VEGF antibody was administered to hypophysectomized-hysterectomized rats simultaneously with estradiol. The recovery in the vascular density, CL weight, and serum progesterone concentration caused by estradiol was significantly inhibited by the anti-VEGF antibody treatment. In conclusion, the present study has demonstrated that VEGF contributes to luteal angiogenesis, CL development, and progesterone production during mid-pregnancy in rats and that luteal VEGF expression is increased by estradiol.


Subject(s)
Corpus Luteum/blood supply , Endothelial Growth Factors/physiology , Lymphokines/physiology , Animals , Antibodies/pharmacology , Corpus Luteum/chemistry , Endothelial Growth Factors/analysis , Endothelial Growth Factors/genetics , Estradiol/blood , Estradiol/pharmacology , Female , Hypophysectomy , Hysterectomy , Immunohistochemistry , Lymphokines/analysis , Lymphokines/genetics , Neovascularization, Physiologic , Pregnancy , Progesterone/blood , RNA, Messenger/analysis , Rats , Rats, Sprague-Dawley , Reverse Transcriptase Polymerase Chain Reaction , Vascular Endothelial Growth Factor A , Vascular Endothelial Growth Factors
20.
J Clin Endocrinol Metab ; 85(11): 4379-86, 2000 Nov.
Article in English | MEDLINE | ID: mdl-11095483

ABSTRACT

To investigate the relationship between apoptosis and the Bcl-2/ Bax system in the human corpus luteum (CL), the frequency of apoptosis and expression of Bcl-2 and Bax were examined in the CL during the menstrual cycle and in early pregnancy. In situ analysis of DNA fragmentation showed that the number of apoptotic cells was much greater in the regressing CL than that in the midluteal phase CL, whereas there were almost no apoptotic cells in the CL of early pregnancy. Immunohistochemistry revealed that Bcl-2 expression was observed in the luteal cells in the midluteal phase and early pregnancy, but not in the regressing CL. In contrast, Bax immunostaining was observed in the regressing CL, but not in the midluteal phase and early pregnancy. bcl-2 messenger ribonucleic acid (mRNA) levels in the CL during the menstrual cycle were highest in the midluteal phase and lowest in the regressing CL. In the CL of early pregnancy, bcl-2 mRNA levels were significantly higher than those in the midluteal phase. In contrast, bax mRNA levels were highest in the regressing CL and remarkably low in the CL of early pregnancy. Western blot analyses revealed that Bcl-2 expression was significantly lower in the regressing CL than in the midluteal phase and early pregnancy, and that Bax expression was, in contrast, significantly higher in the regressing CL than in the midluteal phase and was remarkably low in the CL of early pregnancy. When corpora lutea of the midluteal phase were incubated with hCG, hCG significantly increased the mRNA and protein levels of Bcl-2 and significantly decreased those of Bax. In conclusion, Bcl-2 and Bax may play important roles in the regulation of the life span of the human CL by controlling the rate of apoptosis. hCG may act to prolong the life span of the CL by increasing Bcl-2 expression and decreasing Bax expression when pregnancy occurs.


Subject(s)
Apoptosis , Chorionic Gonadotropin/physiology , Corpus Luteum/physiology , Gene Expression Regulation , Menstrual Cycle/physiology , Pregnancy/physiology , Proto-Oncogene Proteins c-bcl-2/genetics , Proto-Oncogene Proteins/genetics , Adult , Chorionic Gonadotropin/pharmacology , Corpus Luteum/cytology , Corpus Luteum/pathology , Female , Gene Expression Regulation/drug effects , Humans , Leiomyoma/genetics , Leiomyoma/pathology , Leiomyoma/surgery , Middle Aged , Proto-Oncogene Proteins/analysis , Proto-Oncogene Proteins c-bcl-2/analysis , Uterine Cervical Neoplasms/genetics , Uterine Cervical Neoplasms/pathology , Uterine Cervical Neoplasms/surgery , Uterine Neoplasms/genetics , Uterine Neoplasms/pathology , Uterine Neoplasms/surgery , bcl-2-Associated X Protein
SELECTION OF CITATIONS
SEARCH DETAIL
...